Skip to main content
. 2020 Aug 13;26:78. doi: 10.1186/s10020-020-00208-9

Fig. 3.

Fig. 3

Novel nomogram to predict the prognosis of immune checkpoint inhibitor (ICI) treatment. a The survival curves for ICIs-treated patients based on the EGFR mutational status; b. The survival curves for ICIs-treated patients based on the ARID1B mutational status; c. The survival curves for ICIs-treated patients based on PD-L1 expression; d. The survival curves for ICIs-treated patients based on the tumor mutational burden (TMB); e. The survival curves for ICIs-treated patients based on treatment lines; f. The survival curves for ICIs-treated patients based on smoking history; g. The novel nomogram based on patient information to predict the prognosis of ICI treatment; h. The calibration plot for the nomogram